Venetoclax Combo Therapy Shows Promise in Pediatric Patients with R/R AML

Leggi l'articolo originale


Early data on the safety and tolerability of combination venetoclax and cytarabine or cytarabine/idarubicin were presented at ASCO 2019.

Lascia un commento